{
  "type": "hyp",
  "text": "This is the first report of increased fms-like tyrosine kinase-1 activity in human melanoma and suggests that increased fms-like tyrosine kinase-1 activity may be involved in melanoma progression.\n",
  "self": {
    "NER": {
      "answers": [
        "first"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What is the first report of increased fms-like tyrosine"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "the first report",
        "increased fms-like tyrosine kinase-1 activity",
        "human melanoma",
        "increased fms-like tyrosine kinase-1 activity",
        "melanoma progression"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What is the first report of increased fms-like tyrosine",
          "What is the first report of in human melanoma?",
          "What is the first report of increased fms-like tyrosine",
          "What is the first report of in human melanoma?",
          "What is the first report of increased fms-like tyrosine"
        ]
      }
    }
  },
  "asked": {
    "What is associated with increased soluble fms-like tyrosine": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.02942478656768799,
        "ground_truth": {
          "Maternal endothelial dysfunction": {
            "bertscore": 0.6426212787628174,
            "f1": 0
          }
        }
      }
    },
    "What is the most common type of maternal endothelial dysfunction?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 1.7642974853515625e-05,
        "ground_truth": {
          "preeclampsia": {
            "bertscore": 0.6545172929763794,
            "f1": 0
          }
        }
      }
    },
    "What is the cause of maternal endothelial dysfunction?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 1.4185905456542969e-05,
        "ground_truth": {
          "increased soluble fms-like tyrosine kinase-1": {
            "bertscore": 0.6032078266143799,
            "f1": 0
          }
        }
      }
    },
    "What is the circulating antagonist of vascular endothelial growth factor and placen": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0036118030548095703,
        "ground_truth": {
          "(sFlt-1": {
            "bertscore": 0.6571569442749023,
            "f1": 0
          }
        }
      }
    },
    "What is sFlt-1?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.004944801330566406,
        "ground_truth": {
          "a circulating antagonist": {
            "bertscore": 0.66375333070755,
            "f1": 0
          }
        }
      }
    },
    "What is sFlt-1 an antagonist of?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0006396174430847168,
        "ground_truth": {
          "vascular endothelial growth factor": {
            "bertscore": 0.6188154220581055,
            "f1": 0
          },
          "placental growth factor": {
            "bertscore": 0.6410683393478394,
            "f1": 0
          }
        }
      }
    }
  }
}